US Stock MarketDetailed Quotes

DYN Dyne Therapeutics

Watchlist

23.695
-1.285-5.14%

Close Apr 25 16:00 ET

23.695
0.0000.00%

Post 16:20 ET

2.04BMarket Cap-5998P/E (TTM)

Dyne Therapeutics Stock Forum

Moomoo AI

Mar 25 19:38

John Cox's appointment, with his vast biotech industry and rare disease commercialization experience, is viewed positively for Dyne Therapeutics. His leadership is anticipated to enhance the company's clinical programs and pipeline, and build more capabilities as Dyne continues to create stakeholder value.

Press Release: Dyne Therapeutics Announces CEO Transition

SlowndEasyWins

Mar 24 07:07

$Dyne Therapeutics(DYN.US)$ 🐂37.79~55.89 upswing might be risk free 🟢 zone

Moomoo AI

Mar 15 19:12

Recent insider share sale at current price raises slight concern. Lack of insider buying and low level of insider ownership over the past year do not inspire excitement about the stock.

Chief Operating Officer Of Dyne Therapeutics Sold 71% Of Their Shares

Moomoo AI

Jan 27 20:53

The lack of recent insider transactions and low insider ownership at Dyne Therapeutics doesn't inspire confidence. Insider sales at prices above current levels could suggest contentment with lower valuations, potentially a weak sign for future stock performance.

More Money In The Bank For Dyne Therapeutics Insiders Who Divested US$751k

Meltyy

Jan 12 23:27

Biotech Stock News 01/12 @ Open 🛎️📰
$Dyne Therapeutics(DYN.US)$ 4% Closing of public offering
$Geron(GERN.US)$ 4% Participate @ B. Riley Sec. Conf. '24
$ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS(ZEAL.US)$ 2% Capital increase
$XOMA Corp(XOMA.US)$ 1% Arimoclomol NDA filing accepted
$Cellectar BioSciences(CLRB.US)$ 1% Topline results @ conf. call
$CytomX(CTMX.US)$ 0% Present @ B. Riley Sec. Conf. '24

Trytosaveabit

Jan 12 05:06

Update

$Dyne Therapeutics(DYN.US)$ Press Release: Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
Dow Jones· just